ACHE and Alzheimer disease: HupA is a potent, reversible, and selective acetylcholinesterase inhibitor (AChEI) and has demonstrated efficacy in the treatment of Alzheimer’s disease (AD) (Ferreira et al., 2016; Bai, 2007; Little et al., 2008; Zhou et al., 2001; Wu et al., 2011).